Irene Ghobrial
Harvard University
H-index: 101
North America-United States
Top articles of Irene Ghobrial
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Editor's Note: Targeting Akt and Heat Shock Protein 90 Produces Synergistic Multiple Myeloma Cell Cytotoxicity in the Bone Marrow Microenvironment | Clinical Cancer Research | Alissa Huston Xavier Leleu Xiaoying Jia Anne-Sophie Moreau Hai T Ngo | 2024/2/16 |
Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma | Clinical Cancer Research | Dickran Kazandjian Benjamin Diamond Marios Papadimitriou Elizabeth Hill Romanos Sklavenitis-Pistofidis | 2024/4/23 |
Editor's Note: Eph-B2/Ephrin-B2 Interaction Plays a Major Role in the Adhesion and Proliferation of Waldenstrom's Macroglobulinemia | Clinical Cancer Research | Feda Azab Abdel Kareem Azab Patricia Maiso Teresa Calimeri Ludmila Flores | 2024/2/16 |
MYC dependency in GLS1 and NAMPT is a therapeutic vulnerability in multiple myeloma | Iscience | Lama Hasan Bou Issa Léa Fléchon William Laine Aicha Ouelkdite Silvia Gaggero | 2024/4/19 |
Editor's Note: Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom Macroglobulinemia | Clinical Cancer Research | Aldo M Roccaro Antonio Sacco Xiaojing Jia Ranjit Banwait Patricia Maiso | 2024/2/16 |
Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk population | Blood Advances | David J Lee Habib El-Khoury Angela C Tramontano Jean-Baptiste Alberge Jacqueline Perry | 2024/4/9 |
Non-relapse mortality after CAR T-cell therapy: A systematic review and meta-analysis of 7,788 lymphoma and myeloma patients | Kai Rejeski David Cordas dos Santos Tobias Tix Roni Shouval Edward Scheffer Cliff | 2024/2/1 | |
Genomic profiling of Mycosis Fungoides identifies patients at high risk of disease progression | Blood Advances | Léa Fléchon Inès Arib Ankit K Dutta Lama Hasan Bou Issa Romanos Sklavenitis-Pistofidis | 2024/3/21 |
Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib … | medRxiv | Omar Nadeem Michelle Aranha Robert Redd Michael Timonian Sophie Magidson | 2024 |
Design and Rationale of Prolonged Nightly Fasting for Multiple Myeloma Prevention (PROFAST): Protocol for a Randomized Controlled Pilot Trial | JMIR Research Protocols | David J Lee Elizabeth K O'Donnell Noopur Raje Cristina Panaroni Robert Redd | 2024/3/11 |
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma | Irene M Ghobrial Nicole Gormley Shaji K Kumar Maria-Victoria Mateos P Leif Bergsagel | 2024/5/1 | |
OA-22 TiMMing: developing an innovative suite of bioinformatic tools to harmonize and track the origin of copy number alterations in the evolutionary history of multiple myeloma | Clinical Lymphoma Myeloma and Leukemia | Andrea Poletti Jean-Baptiste Alberge Gaia Mazzocchetti Vincenza Solli Ajsi Kanapari | 2023/9/1 |
P-035 Real world experience of patients treated with teclistamab: a BCMA-directed bispecific T-cell engaging therapy for multiple myeloma | Clinical Lymphoma Myeloma and Leukemia | Shonali Midha Houry Leblebjian Jacob Laubach Clifton Mo Adam Sperling | 2023/9/1 |
P-411 Large-scale single-cell dissection of immune dysregulation in patients with monoclonal gammopathies | Clinical Lymphoma Myeloma and Leukemia | Romanos Sklavenitis-Pistofidis Ting Wu Elizabeth Lightbody Yoshinobu Konishi Mahshid Rahmat | 2023/9/1 |
Discovery of First-in-Class Small Molecule Inhibitors of the IRF4-PU. 1/Spi-B Interaction | Blood | Mike P Agius Laura Hevenor N Connor Payne Ralph Mazitschek Hyuk-Soo Seo | 2023/11/28 |
Understanding Patient Preferences for Intervention in Individuals with Precursor Multiple Myeloma: The Preference Study | Blood | Catherine R Marinac Katelyn Downy Irene M Ghobrial Jacqueline Perry Brittany Fischer-Longden | 2023/11/28 |
Clinical outcomes and evolution of clonal hematopoiesis in patients with newly diagnosed multiple myeloma | Cancer Research Communications | Tarek H Mouhieddine Chidimma Nzerem Robert Redd Andrew Dunford Matthew Leventhal | 2023/12/18 |
MinimuMM-seq: Genome sequencing of circulating tumor cells for minimally invasive molecular characterization of multiple myeloma pathology | Cancer discovery | Ankit K Dutta Jean-Baptiste Alberge Elizabeth D Lightbody Cody J Boehner Andrew Dunford | 2023/2/6 |
Monoclonal B-cell lymphocytosis, monoclonal gammopathy of undetermined significance, and T-cell clones of uncertain significance: are these premalignant conditions sharing a … | Gianpietro Semenzato Irene M Ghobrial Paolo Ghia | 2023/7/1 | |
OA-35 High-throughput plasma proteomics to define the precursor multiple myeloma proteome and identify candidate high-risk disease biomarkers of progression | Clinical Lymphoma Myeloma and Leukemia | Elizabeth Lightbody DR Mani Hasmik Keshishian Habib El-Khoury Ankit Dutta | 2023/9/1 |
